Paradigm uses OpenAI API to improve clinical trial patient access
AI Impact Summary
Paradigm is leveraging the OpenAI API to enhance patient engagement with clinical trials by automating the matching of patient profiles to relevant trial opportunities. This represents a shift towards AI-driven patient recruitment, potentially reducing the time and cost associated with traditional methods. The integration likely involves using OpenAI’s models for natural language processing to analyze patient data and trial descriptions, identifying potential matches.
Affected Systems
Business Impact
Improved patient matching through the OpenAI API could accelerate clinical trial recruitment and reduce the time to market for new therapies.
- Date
- Date not specified
- Change type
- capability
- Severity
- medium